BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35277361)

  • 1. Concordance between reported medication taking behavior and prescription instructions for patients with chronic obstructive pulmonary disease visiting community pharmacies.
    Prosser TR; Bollmeier SG
    J Am Pharm Assoc (2003); 2022; 62(4):1280-1286. PubMed ID: 35277361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consistency of chronic obstructive pulmonary disease regimens for patients visiting community pharmacies with the Global Initiative for Chronic Obstructive Lung Disease recommendations.
    Prosser TR; Bollmeier SG
    J Am Pharm Assoc (2003); 2021; 61(3):299-307. PubMed ID: 33549503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis.
    Oba Y; Keeney E; Ghatehorde N; Dias S
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012620. PubMed ID: 30521694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.
    Asche CV; Leader S; Plauschinat C; Raparla S; Yan M; Ye X; Young D
    Int J Chron Obstruct Pulmon Dis; 2012; 7():201-9. PubMed ID: 22500120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS.
    Ghosh S; Anderson WH; Putcha N; Han MK; Curtis JL; Criner GJ; Dransfield MT; Barr RG; Krishnan JA; Lazarus SC; Cooper CB; Paine R; Peters SP; Hansel NN; Martinez FJ; Drummond MB;
    Ann Am Thorac Soc; 2019 Feb; 16(2):200-208. PubMed ID: 30216731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study.
    Wurst KE; St Laurent S; Mullerova H; Davis KJ
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1021-31. PubMed ID: 25285002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.
    Price D; West D; Brusselle G; Gruffydd-Jones K; Jones R; Miravitlles M; Rossi A; Hutton C; Ashton VL; Stewart R; Bichel K
    Int J Chron Obstruct Pulmon Dis; 2014; 9():889-904. PubMed ID: 25210450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Adherence to Maintenance Medication in Patients with COPD and Acute Exacerbation Occurrence and Cost in China: A Retrospective Cohort Database Study.
    Chen R; Gao Y; Wang H; Shang H; Xuan J
    Int J Chron Obstruct Pulmon Dis; 2020; 15():963-971. PubMed ID: 32440108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice.
    Chalmers JD; Tebboth A; Gayle A; Ternouth A; Ramscar N
    NPJ Prim Care Respir Med; 2017 Jun; 27(1):43. PubMed ID: 28663549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
    Casas A; Montes de Oca M; Menezes AM; Wehrmeister FC; Lopez Varela MV; Mendoza L; Ramírez L; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1545-1556. PubMed ID: 29785104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Medication Regimen Complexity of COPD Regimens in Individuals Visiting Community Pharmacies.
    Prosser TR; Bollmeier SG
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1499-1510. PubMed ID: 37489240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β
    Skolnik NS; Nguyen TS; Shrestha A; Ray R; Corbridge TC; Brunton SA
    Postgrad Med; 2020 Mar; 132(2):198-205. PubMed ID: 31900019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis.
    Price D; Miravitlles M; Pavord I; Thomas M; Wedzicha J; Haughney J; Bichel K; West D
    NPJ Prim Care Respir Med; 2016 Nov; 26():16061. PubMed ID: 27808096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and Evolution Using the HealthStat Database.
    Milea D; Yeo SH; Nam Y; Navarro Rojas AA; Shantakumar S; Beale J; Marett B; Young RP; Scott RJ; Gribben B
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1075-1091. PubMed ID: 33907394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
    Petite SE
    Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β
    Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E
    Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care.
    Punekar YS; Landis SH; Wurst K; Le H
    Respir Res; 2015 Nov; 16():141. PubMed ID: 26572740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbid Anxiety and Depression, Though Underdiagnosed, Are Not Associated with High Rates of Low-Value Care in Patients with Chronic Obstructive Pulmonary Disease.
    Griffith MF; Chen HP; Bekelman DB; Feemster LC; Spece LJ; Donovan LM; Au DH; Carey EP
    Ann Am Thorac Soc; 2021 Mar; 18(3):442-451. PubMed ID: 33306930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.